Cedars Sinai

Cedars Sinai

Signal active

Investment Firm

Overview

Cedars-Sinai is a non-profit, academic, community-centric medical center in Los Angeles, California. Recognized internationally, Cedars-Sinai brings together top healthcare professionals collaborating to provide exceptional patient care.

Highlights

Founded

1902

Industry

Communities

Employees

10001+

Investment

21

Lead Investment

3

Exits

4

Stages

Early Stage Venture, Seed, Late Stage Venture, Private Equity

Investor Type

N/A

Location

United States, North America

Contact Information

Social

Profile Resume

Cedars Sinai, established in 1902 and headquartered in United States, North America., specializes in Early Stage Venture, Seed, Late Stage Venture, Private Equity investments across Analytics, Health Care, Information Technology, Biotechnology, Life Science, Medical, Financial Services, Venture Capital, Nanotechnology, Therapeutics. The organization boasts a portfolio of 20 investments, with an average round size of $30.0M and 4 successful exits. Their recent investments include Health Care DataWorks, MemorialCare Innovation Fund, Emulate, +ND Capital, Capricor Therapeutics. The highest investment round they participated in was $58.2B. Among their most notable exits are Health Care DataWorks and MemorialCare Innovation Fund. Explore their portfolio in detail, see who is connected to them, and find their contact information on our platform.

Employees

imagePlace Raj Khandwalla

Raj Khandwalla

Director of Digital Therapeutics

imagePlace Thomas Priselac

Thomas Priselac

CEO & President

imagePlace Linda Bolton

Linda Bolton

Senior Vice President & Chief Health Equity Officer

imagePlace Michael Langberg

Michael Langberg

Senior Vice President of Medical Affairs & Chief Medical Officer

imagePlace Arthur Ochoa

Arthur Ochoa

SVP, Advancement & CAO

imagePlace Edward Prunchunas

Edward Prunchunas

Executive Consultant

Investment portfolio

Cedars Sinai has made 21 investments. Their most recent investment was on Jul 17, 2023, when K Health raised $59.0M.

Cedars Sinai has made 7 diversity investments. Their most recent diversity investment was on Jun 22, 2022, when Gemelli Biotech raised $19.0M.

investments

21

Diversity investments

7

Lead investments

3

Number of exits

4

Investments

21

Annouced DateOrganization NameIndustryMoney Raised
Nov 09, 2022
Fathom Fathom
Software46.0M
Jan 11, 2023--9.0M
Jul 17, 2023
K Health K Health
Information Technology59.0M
Aug 01, 2023
Syntho Syntho
Softwarenull

Exits

4

Funding Timeline

Funding rounds

21

Investors

5

Funds

0

Funding Rounds

21

Cedars Sinai has raised 21 rounds. Their latest funding was raised on Aug 01, 2023 from a Seed Round - Syntho round.

Annouced DateTransaction NameNumber of InvestorsMoney RaisedLead Investor
Nov 09, 2022
Series B - Fathom Series B - Fathom
-46.0M-
Jan 11, 2023
Venture Round - Censinet Venture Round - Censinet
-9.0M-
Jul 17, 2023
Venture Round - K Health Venture Round - K Health
-59.0M-
Aug 01, 2023
Seed Round - Syntho Seed Round - Syntho
-0-

Investors

6

Cedars Sinai is funded by 6 investor(s). American Academy of Orthopaedic Surgeons and California HealthCare Foundation Kantor are the most recent investors.

Fund raised

2

Susa Ventures has raised a total of $590M across 6 funds, their latest being Susa Ventures Opportunities II. This fund was announced on Aug 30, 2021 and raised a total of $250M.

Annouced DateFund NameMoney Raised
May 10, 2013
fund image OTPPLESS
1.0M
May 11, 2013
fund image OTPPLESS
1.0M

Invest in industries

Recent Activity

There is no recent news or activity for this profile.